Ian Shakil - 09 Apr 2024 Form 4 Insider Report for Augmedix, Inc.

Role
CHIEF STRATEGY OFFICER, Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Apr 2024
Net transactions value
-$292,647
Form type
4
Filing time
11 Apr 2024, 20:30:07 UTC
Previous filing
09 Apr 2024
Next filing
15 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise $9,188 +14,356 +479% $0.6400 17,356 09 Apr 2024 Direct F1
transaction AUGX Common Stock Options Exercise $14,780 +17,186 +99% $0.8600 34,542 09 Apr 2024 Direct F1
transaction AUGX Common Stock Sale $130,521 -31,542 -91% $4.14 3,000 09 Apr 2024 Direct F1, F2
transaction AUGX Common Stock Options Exercise $31,362 +36,467 +1216% $0.8600 39,467 10 Apr 2024 Direct F1
transaction AUGX Common Stock Sale $141,288 -36,467 -92% $3.87 3,000 10 Apr 2024 Direct F1, F3
transaction AUGX Common Stock Options Exercise $21,309 +24,778 +826% $0.8600 27,778 11 Apr 2024 Direct F1
transaction AUGX Common Stock Sale $97,477 -24,778 -89% $3.93 3,000 11 Apr 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -14,356 -100% $0.000000* 0 09 Apr 2024 Common Stock 14,356 $0.6400 Direct F1, F5
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -17,186 -3.1% $0.000000 537,238 09 Apr 2024 Common Stock 17,186 $0.8600 Direct F1, F5
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -36,467 -6.8% $0.000000 500,771 10 Apr 2024 Common Stock 36,467 $0.8600 Direct F1, F5
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -24,778 -4.9% $0.000000 475,993 11 Apr 2024 Common Stock 24,778 $0.8600 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades ranging from $4.0600 to $4.2400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 This transaction was executed in multiple trades ranging from $3.8000 to $4.0400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 This transaction was executed in multiple trades ranging from $3.8200 to $4.0000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 Fully vested.